| dc.contributor.author | Ranju Baral, Ann Levin, Chris Odero, Clint Pecenka, John Tanko Bawa, Kwadwo Odei Antwi-Agyei, Kwame Amponsa-Achaino, Mike Nenani Chisema, Rose Eddah Jalango, Rouden Mkisi, Scott Gordon, Winthrop Morgan, Farzana Muhib | |
| dc.date.accessioned | 2023-03-08T13:40:31Z | |
| dc.date.available | 2023-03-08T13:40:31Z | |
| dc.date.issued | 2023 | |
| dc.identifier.uri | https://repository.maseno.ac.ke/handle/123456789/5632 | |
| dc.description | https://doi.org/10.1016/j.vaccine.2023.01.043 | en_US |
| dc.description.abstract | The World Health Organization (WHO) recommended widespread use of the RTS,S/AS01 (RTS,S) malaria vaccine among children residing in regions of moderate to high malaria transmission. This recommendation is informed by RTS,S evidence, including findings from the pilot rollout of the vaccine in Ghana, Kenya, and Malawi. This study estimates the incremental costs of introducing and delivering the malaria vaccine within routine immunization programs in the context of malaria vaccine pilot introduction, to help inform decision-making. | en_US |
| dc.publisher | Elsevier | en_US |
| dc.subject | Cost;Cost of delivery;Cost of introduction;Malaria vaccine;Financial cost;Economic cost | en_US |
| dc.title | Cost of introducing and delivering RTS, S/AS01 malaria vaccine within the malaria vaccine implementation program | en_US |
| dc.type | Article | en_US |
